Original Research

Published on 25 Sep 2024

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response

in Immunosuppression

Moritz Anft
Panagiota Zgoura
Sarah Skrzypczyk
Michael Dürr
Richard Viebahn
Timm H. Westhoff
Ulrik Stervbo
Nina Babel

Frontiers in Transplantation

doi 10.3389/frtra.2024.1405070

405 views

Brief Research Report

Published on 09 Sep 2024

Propionic acid supplementation promotes the expansion of regulatory T cells in patients with end-stage renal disease but not in renal transplant patients

in Immunosuppression

Moritz Anft
Fabian Meyer
Sirin Czygan
Felix S. Seibert
Benjamin J. Rohn
Fotios Tsimas
Richard Viebahn
Timm H. Westhoff
Ulrik Stervbo
Nina Babel

Frontiers in Transplantation

doi 10.3389/frtra.2024.1404740

406 views

Editorial

Published on 10 Apr 2024

Editorial: Antibody-mediated rejection

in Immunosuppression

Ramsey R. Hachem
Thalachallour Mohanakumar

Frontiers in Transplantation

doi 10.3389/frtra.2024.1408225

523 views

Review

Published on 24 Jan 2024

BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients

in Immunosuppression

Sandesh Parajuli
Fahad Aziz
Weixiong Zhong
Arjang Djamali

Frontiers in Transplantation

doi 10.3389/frtra.2024.1309927

1,374 views

Brief Research Report

Published on 11 Jan 2024

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression

in Immunosuppression

Jean L. Koff
Geeta M. Karadkhele
Jeffrey M. Switchenko
Manali Rupji
Kendra Little
Christian P. Larsen

Frontiers in Transplantation

doi 10.3389/frtra.2023.1280993

1,124 views

Review

Published on 08 Dec 2023

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

in Immunosuppression

Corinne E. Praska
Riccardo Tamburrini
Juan Sebastian Danobeitia

Frontiers in Transplantation

doi 10.3389/frtra.2023.1277669

1,012 views

Clinical Trial

Published on 21 Nov 2023

Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy

in Immunosuppression

Aurélie Philippe
Wolfgang Arns
Vanessa Ditt
Ingeborg A. Hauser
Friedrich Thaiss
Claudia Sommerer
Barbara Suwelack
Duska Dragun
Jan Hillen
Christiane Schiedel

Frontiers in Transplantation

doi 10.3389/frtra.2023.1273890

951 views
3 citations

Original Research

Published on 09 Nov 2023

Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells

in Immunosuppression

Shilei Xu
Sebastian Dolff
Nils Mülling
Hagen S. Bachmann
Yang Dai
Monika Lindemann
Ming Sun
Oliver Witzke
Andreas Kribben
Benjamin Wilde

Frontiers in Transplantation

doi 10.3389/frtra.2023.1233322

896 views

Review

Published on 09 Nov 2023

The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction

in Immunosuppression

Wenbin Yang
Emilia Lecuona
Qiang Wu
Xianpeng Liu
Haiying Sun
Hasan Alam
Satish N. Nadig
Ankit Bharat

Frontiers in Transplantation

doi 10.3389/frtra.2023.1237671

879 views

Original Research

Published on 30 Oct 2023

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies

in Immunosuppression

Stephanie Ji
Hao Liu
Laura Pachella
Ryan D. Stephenson
Roman Groisberg
Sarah A. Weiss

Frontiers in Transplantation

doi 10.3389/frtra.2023.1284740

1,495 views
1 citation

Original Research

Published on 16 Oct 2023

Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring

in Immunosuppression

Arlisson Macedo Rodrigues
Mariana Tavares Tanno
Mariana Moraes Contti
Hong Si Nga
Mariana Farina Valiatti
Silvana Daher Costa
Tainá Veras de Sandes-Freitas
Ronaldo de Matos Esmeraldo
Camila Marinho Assunção
Juliana Bastos Campos Tassi

Frontiers in Transplantation

doi 10.3389/frtra.2023.1279940

1,004 views

Review

Published on 29 Sep 2023

Management of donor-specific antibodies in lung transplantation

in Immunosuppression

William Brandon
Colin Dunn
Srinivas Bollineni
John Joerns
Adrian Lawrence
Manish Mohanka
Irina Timofte
Fernando Torres
Vaidehi Kaza

Frontiers in Transplantation

doi 10.3389/frtra.2023.1248284

1,573 views

Original Research

Published on 04 Sep 2023

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients

in Immunosuppression

Sandhya Bansal
Ashwini Arjuna
Brian Franz
Alexa Guerrero-Alba
Jesse Canez
Timothy Fleming
Mohammad Rahman
Ramsey Hachem
T. Mohanakumar

Frontiers in Transplantation

doi 10.3389/frtra.2023.1248987

1,127 views

Original Research

Published on 01 Sep 2023

Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model

in Immunosuppression

Robin Schmitz
Miriam Manook
Zachary Fitch
Imran Anwar
Isabel DeLaura
Danae Olaso
Ashley Choi
Janghoon Yoon
Yeeun Bae
Mingqing Song

Frontiers in Transplantation

doi 10.3389/frtra.2023.1230393

1,175 views

Review

Published on 21 Aug 2023

Tacrolimus—why pharmacokinetics matter in the clinic

in Immunosuppression

Lino Henkel
Ulrich Jehn
Gerold Thölking
Stefan Reuter

Frontiers in Transplantation

doi 10.3389/frtra.2023.1160752

4,845 views
1 citation

Review

Published on 28 Apr 2023

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation

in Immunosuppression

Adriana Franco-Acevedo
Johanna Comes
Julia J. Mack
Nicole M. Valenzuela

Frontiers in Transplantation

doi 10.3389/frtra.2023.1146040

1,539 views
2 citations

Navigation group

Articles

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response

Propionic acid supplementation promotes the expansion of regulatory T cells in patients with end-stage renal disease but not in renal transplant patients

Editorial: Antibody-mediated rejection

BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

Impact of everolimus plus calcineurin inhibitor on formation of non-HLA antibodies and graft outcomes in kidney transplant recipients: 12-month results from the ATHENA substudy

Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells

The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction

Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies

Renal function at 12 months of kidney transplantation comparing tacrolimus and mycophenolate with tacrolimus and mTORi in donors with different KDPI ranges. A multicenter cohort study using propensity scoring

Management of donor-specific antibodies in lung transplantation

Extracellular vesicles: a potential new player in antibody-mediated rejection in lung allograft recipients

Belatacept and carfilzomib-based treatment for antibody-mediated rejection in a sensitized nonhuman primate kidney transplantation model

Tacrolimus—why pharmacokinetics matter in the clinic

New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation